Back-to-Back 52-Week Highs; This Multibagger penny stock under Rs 35 Log 100% Returns on YTD Basis; Here is Why

Take Solutions Ltd continued its strong upward trajectory as the stock hit a fresh 52-week high on Tuesday, extending its impressive year-to-date (YTD) gains of more than 100 per cent. The stock also touched its highest level in 21 months, driven by renewed investor interest despite muted operational performance in recent quarters. On Tuesday, the company’s shares were trading at Rs 33.13, up 1.88 per cent. Meanwhile, domestic markets were expected to open flat on Wednesday, with the GIFT Nifty quoting near 26,207—just 1 point above Tuesday’s Nifty futures close—suggesting a muted start for the Indian indices.

Take Solutions has remained in focus due to its sharp price recovery and multiple 52-week highs registered over the past week. In the last three months alone, the stock has delivered multibagger returns of nearly 200 per cent. Over a one-year period, the company has returned 94 per cent, while the 18-month gain stands at an impressive 289 per cent.

The company declared its Q2 FY26 financial results on October 27, 2025. Take Solutions reported zero operational revenue in Q2 FY26, similar to Q2 FY25, while Q1 FY26 had generated a modest Rs 0.04 crore revenue figure. Despite this, the company posted a consolidated net profit of Rs 6.29 crore in Q2 FY26, compared to a loss of Rs 1.58 crore in the corresponding quarter last year. The profit also marks a recovery from the Rs 0.91 crore loss in Q1 FY26. This improvement was largely driven by gains from discontinued operations of its wholly owned subsidiary, Ecron Acunova Limited (EAL), indicating that the bottom-line growth did not come from ongoing business activities.

A significant development occurred on November 10, 2025, when Take Solutions disclosed that its Promoter group entity, Esyspro Infotech Limited, had fully exited the company. According to the filing dated November 8, 2025, Esyspro Infotech sold 75,40,998 shares in an off-market deal executed on November 6, 2025. This stake was valued at Rs 52,78,698 (excluding Taxes, brokerage, or additional charges). Prior to the sale, the entity held a 5.10 per cent stake in the company, and the divestment has brought its holding down to zero.

Take Solutions, founded in 2000 and headquartered in Chennai, operates in the Life Sciences and Supply Chain Management sectors. The company provides technology-driven services such as clinical research support, regulatory submission assistance, pharmacovigilance, and safety compliance solutions. Its offerings also extend to supply chain automation, engineering support, and process re-engineering. Over the years, it has catered to pharmaceutical, biotech, medical device, and generics manufacturers across India, the US, Europe, and other global markets.

With a market capitalisation of around Rs 490 crore, Take Solutions continues to attract investor attention despite the lack of operational revenue visibility. The stock’s back-to-back 52-week highs highlight strong sentiment around its restructuring efforts and potential recovery. However, the company’s financial performance remains heavily dependent on non-operational gains, which investors should keep in mind while evaluating future prospects.

Disclaimer: The article is for informational purposes only and not investment advice.